Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors
- 3 October 1994
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 659 (1-2) , 62-66
- https://doi.org/10.1016/0006-8993(94)90863-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumorsJournal of Neurosurgery, 1994
- Bradykinin Selectively Opens Blood-Tumor Barrier in Experimental Brain TumorsJournal of Cerebral Blood Flow & Metabolism, 1994
- Central bradykininergic system in normotensive and hypertensive ratsClinical Science, 1992
- Model for Drug Uptake by Brain Tumors: Effects of Osmotic Treatment and of Diffusion in BrainJournal of Cerebral Blood Flow & Metabolism, 1990
- Pharmacological Modification of Bradykinin Induced Breakdown of the Blood-brain BarrierCanadian Journal of Neurological Sciences, 1986
- Opening the blood–brain and blood–tumor barriers in experimental rat brain tumors: The effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flowAnnals of Neurology, 1986
- Osmotic Blood-Brain Barrier Modification: Monoclonal Antibody, Albumin, and Methotrexate Delivery to Cerebrospinal Fluid and BrainNeurosurgery, 1985
- Osmotic Blood-Brain Barrier Modification and Combination Chemotherapy: Concurrent Tumor Regression in Areas of Barrier Opening and Progression in Brain Regions Distant to Barrier OpeningNeurosurgery, 1984
- NEUROTOXICITY OF VINCRISTINE AFTER THE OSMOTIC OPENING OF THE BLOOD‐BRAIN BARRIERNeuropathology and Applied Neurobiology, 1983
- Permeability of Different Experimental Brain Tumor Models to Horseradish PeroxidaseJournal of Neuropathology and Experimental Neurology, 1982